Glucagon has attractive traits in the diabetic population due to its simplicity of use and safe administration, not requiring patent IV access. Severe hypoglycemia is a life-threatening event treated with oral carbohydrate intake, IV glucose, or glucagon by various routes. ![]() It is FDA approved for the treatment of severe hypoglycemia. Glucagon is a polypeptide hormone commonly used in the treatment of severe hypoglycemia. Discuss interprofessional team strategies for improving care coordination and communication to advance effective treatment with glucagon and improve outcomes.Review the appropriate monitoring for patients receiving glucagon.Describe the contraindications to glucagon therapy.Identify the mechanism of action of glucagon. ![]() In addition, this activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for healthcare team members in managing patients with the indicated conditions. This activity describes the indications, actions, and contraindications for glucagon as a valuable agent in managing acute hypoglycemia, beta-blockers, and calcium channel blocker overdose, refractory anaphylaxis, and esophageal obstruction due to food bolus. It is in the anti-hypoglycemic class of medications. ![]() ![]() Glucagon is a medication used to manage and treat hypoglycemia as an antidote to beta-blocker and calcium channel blocker overdose, anaphylaxis refractory to epinephrine, and aid in passing food boluses.
0 Comments
Leave a Reply. |